BT7480
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BT7480, covering 2026-01-15 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression [Phase 1, Phase 2]